Clinical Trials Browser

Urinary Bladder Neoplasms, Colonic Neoplasms, Esophageal Neoplasms, Liver Neoplasms, Ovarian Neoplasms, Pancreatic Neoplasms, Stomach Neoplasms, Uterine Neoplasms, Vulvar Neoplasms, Endometrial Neoplasms

NCT05240040 2026-03-23

Treat Primary and Metastatic Liver Tumors

Withdrawn

Gastrointestinal

Carcinoma, Hepatocellular, Liver Neoplasms, Neoplasm Metastasis, Cholangiocarcinoma

NCT06345508 2026-03-20

QUS in HCC

Recruiting

328 enrolled

Gastrointestinal

Disease, Carcinoma, Hepatocellular, Liver Neoplasms

NCT05128032 2026-03-19

PEDIR

Phase NA Active not recruiting

20 enrolled

Gastrointestinal

Carcinoma, Hepatocellular, Liver Neoplasms, Colorectal Neoplasms

NCT07044362 2026-03-19

Histotripsy Plus Chemotherapy vs Chemotherapy Alone for Advanced Colorectal Liver Metastasis

Phase NA Recruiting

100 enrolled

Gastrointestinal

Liver Neoplasms, Colorectal Neoplasms

NCT01165346 2026-03-13

CKNO-HEP

Phase 2 Completed

44 enrolled

Gastrointestinal

Carcinoma, Hepatocellular, Liver Neoplasms

NCT03151213 2026-03-13

pregabalin

Phase 4 Completed

70 enrolled

Gastrointestinal

Liver Neoplasms

NCT07224737 2026-03-13

EXOMIC

Completed

230 enrolled

Gastrointestinal

Cirrhosis, Familial, with Pulmonary Hypertension, Liver Neoplasms, Recurrence, Cholangiocarcinoma

NCT07225452 2026-03-13

LUMIC

Completed

535 enrolled

Gastrointestinal

Cirrhosis, Familial, with Pulmonary Hypertension, Liver Neoplasms, Cholangiocarcinoma

NCT05095714 2026-03-12

FASTRAK

Phase NA Recruiting

944 enrolled

Gastrointestinal

Fibrosis, Carcinoma, Hepatocellular, Liver Neoplasms

NCT07436988 2026-03-12

ReLIVE

Phase 1 Not yet recruiting

18 enrolled

Gastrointestinal

Carcinoma, Hepatocellular, Liver Neoplasms

NCT03028311 2026-03-10

Yttrium Y-90 Radioembolization in Treating Patients With Metastatic Liver Cancer

Phase 1 Active not recruiting

12 enrolled

Gastrointestinal

Carcinoma, Hepatocellular, Liver Neoplasms

NCT05743842 2026-03-09

TriNav Infusion System for the Evaluation of Fidelity Between 99mTc-MAA and Y90-Microspheres Hepatic Distribution for Dosimetry Treatment Planning

Phase NA Active not recruiting

19 enrolled

Gastrointestinal

Liver Neoplasms

NCT07459309 2026-03-09

Clinical Study on the Safety, Efficacy, and Exploration of Immune Mechanisms of a Combined Multimodal Tumor Therapy System for Hepatic Malignancies

Phase NA Not yet recruiting

20 enrolled

Gastrointestinal

Liver Neoplasms, Neoplasm Metastasis

NCT05103631 2026-03-06

Interleukin-15 Armored Glypican 3-specific Chimeric Antigen Receptor Expressed in Autologous T Cells for Solid Tumors

Phase 1 Active not recruiting

12 enrolled

GastrointestinalGenitourinarySarcoma

Carcinoma, Hepatocellular, Liposarcoma, Liver Neoplasms, Wilms Tumor, Rhabdomyosarcoma, Endodermal Sinus Tumor, Rhabdoid Tumor

NCT03582189 2026-03-05

MR Guidance for Liver and Pancreas

Recruiting

30 enrolled

Gastrointestinal

Liver Neoplasms, Pancreatic Neoplasms

NCT04075305 2026-03-05

MOMENTUM

Recruiting

8,000 enrolled

BreastCNSGastrointestinalGenitourinaryHead & NeckThoracic

Urinary Bladder Neoplasms, Brain Neoplasms, Breast Neoplasms, Esophageal Neoplasms, Genital Neoplasms, Female, Head and Neck Neoplasms, Liver Neoplasms, Lung Neoplasms, Neoplasms, Pancreatic Neoplasms, Prostatic Neoplasms, Radiation Injuries, Rectal Neoplasms

NCT07010315 2026-03-04

Development and Testing of a Patient-facing Educational Tool About Liver Cancer Prevention

Recruiting

40 enrolled

Gastrointestinal

Fibrosis, Liver Diseases, Liver Neoplasms

NCT04785287 2026-03-03

Anti-CTLA4-NF mAb (BMS986218), Nivolumab, and Stereotactic Body Radiation Therapy for the Treatment of Metastatic Solid Malignancies

Phase 1/2 Terminated

13 enrolled

EndocrineGastrointestinalThoracic

Adrenal Gland Neoplasms, Carcinoma, Hepatocellular, Liver Neoplasms, Lung Neoplasms, Neoplasm Metastasis

NCT07295275 2026-03-03

Safety and Efficacy of Transarterial ICG Fluorescence-Guided Laparoscopic Anatomical Liver Resection

Recruiting

200 enrolled

Gastrointestinal

Carcinoma, Hepatocellular, Liver Neoplasms

NCT07445412 2026-03-03

I-GROWtoh

Recruiting

2,000 enrolled

Gastrointestinal

Carcinoma, Hepatocellular, Liver Neoplasms, Neoplasm Metastasis

NCT07447050 2026-03-03

Riluzole For Preventing Cognitive Dysfunction in Ca Pts Receiving Chemo (REFOCUS): Pilot Trial

Phase 2 Recruiting

24 enrolled

BreastGastrointestinalGynecologicHead & NeckSarcomaThoracic

Breast Neoplasms, Head and Neck Neoplasms, Liver Neoplasms, Lung Neoplasms, Ovarian Neoplasms, Sarcoma, Stomach Neoplasms, Urogenital Neoplasms, Colorectal Neoplasms

NCT07413640 2026-02-25

MICRO-VAR

Recruiting

90 enrolled

Gastrointestinal

Liver Neoplasms

NCT04134559 2026-02-24

Checkpoint Inhibition In Pediatric Hepatocellular Carcinoma

Phase 2 Recruiting

18 enrolled

Gastrointestinal

Fibrolamellar hepatocellular carcinoma, Carcinoma, Hepatocellular, Liver Neoplasms

NCT07430202 2026-02-24

A DNAJB1-PRKACA Fusion Kinase Peptide Vaccine Combined With Glutamine Antagonist DRP-104, Nivolumab, and Ipilimumab in Patients With Advanced Stage Fibrolamellar Carcinoma (FLC)

Phase 1 Not yet recruiting

27 enrolled

Gastrointestinal

Fibrolamellar hepatocellular carcinoma, Carcinoma, Liver Neoplasms

NCT06458998 2026-02-23

GTI

Phase NA Enrolling by invitation

30,300 enrolled

Gastrointestinal

Colonic Neoplasms, Fibrosis, Liver Neoplasms

NCT04258813 2026-02-20

ONE TEAM

Phase NA Active not recruiting

313 enrolled

BreastGastrointestinalGenitourinaryGynecologicHead & NeckThoracic

Breast Neoplasms, Carcinoma, Non-Small-Cell Lung, Carcinoma, Renal Cell, Cardiovascular Diseases, Colonic Neoplasms, Diabetes Mellitus, Esophageal Neoplasms, Head and Neck Neoplasms, Hypercholesterolemia, Hypertension, Liver Neoplasms, Neoplasms, Ovarian Neoplasms, Pancreatic Neoplasms, Prostatic Neoplasms, Endometrial Neoplasms

NCT04907643 2026-02-20

Virtual Reality for GI Cancer Pain to Improve Patient Reported Outcomes

Phase NA Recruiting

360 enrolled

EndocrineGastrointestinalNET

Cancer Pain, Anus Neoplasms, Appendiceal Neoplasms, Bile Duct Neoplasms, Biliary Tract Neoplasms, Carcinoid Tumor, Colonic Neoplasms, Esophageal Neoplasms, Gallbladder Neoplasms, Gastrointestinal Neoplasms, Liver Neoplasms, Neoplasm Metastasis, Pancreatic Neoplasms, Rectal Neoplasms, Recurrence, Stomach Neoplasms, Neuroendocrine Tumors, Visceral Pain

NCT06958224 2026-02-20

ESCAT

Phase NA Not yet recruiting

360 enrolled

BreastGastrointestinal

Breast Neoplasms, Liver Neoplasms

NCT06608940 2026-02-19

BC3402 w/ Tremelimumab + Durvalumab (STRIDE) in Hepatocellular Carcinoma

Phase 1/2 Withdrawn

Gastrointestinal

Liver Neoplasms

NCT07407257 2026-02-18

SBRT for Liver Tumors, Liver Metastases, and Pancreatic Tumors

Phase NA Completed

65 enrolled

Gastrointestinal

Carcinoma, Hepatocellular, Liver Neoplasms, Pancreatic Neoplasms

NCT07410494 2026-02-18

SELECT-CAR-NK

Phase 1/2 Recruiting

85 enrolled

BreastCNSDermatologicGastrointestinalGenitourinaryGynecologicLymphoidOther hematologic neoplasmPlasma cellThoracic

Breast Neoplasms, Carcinoma, Non-Small-Cell Lung, Glioblastoma, Carcinoma, Hepatocellular, Liver Neoplasms, Lymphoma, Lymphoma, Follicular, Lymphoma, Non-Hodgkin, Melanoma, Multiple Myeloma, Neoplasm Metastasis, Neoplasms, Ovarian Neoplasms, Prostatic Neoplasms, Colorectal Neoplasms, Leukemia, Myeloid, Acute

NCT07410676 2026-02-18

EBNK-ST-001

Phase 1/2 Recruiting

83 enrolled

BreastCNSDermatologicGastrointestinalGenitourinaryGynecologicOther hematologic neoplasmSarcomaThoracic

Urinary Bladder Neoplasms, Breast Neoplasms, Carcinoma, Bronchogenic, Disease, Esophageal Neoplasms, Glioblastoma, Kidney Neoplasms, Leukemia, Liver Neoplasms, Lung Neoplasms, Melanoma, Neoplasm Metastasis, Neoplasms, Ovarian Neoplasms, Pancreatic Neoplasms, Prostatic Neoplasms, Sarcoma, Stomach Neoplasms, Colorectal Neoplasms

NCT03445585 2026-02-17

Biobank for Cholestatic Liver Diseases.

Recruiting

9,150 enrolled

Gastrointestinal

Liver Cirrhosis, Biliary, Liver Neoplasms, Cholangitis, Sclerosing, Cholangiocarcinoma

NCT06261814 2026-02-17

Contrast Enhanced Ultrasound to Evaluate Response to Chemoembolization in Patients With Liver Tumors

Phase 2 Recruiting

266 enrolled

Gastrointestinal

Liver Neoplasms

NCT07148050 2026-02-17

IMPACT

Phase 1 Recruiting

21 enrolled

GastrointestinalGenitourinarySarcoma

Carcinoma, Hepatocellular, Liposarcoma, Liver Neoplasms, Wilms Tumor, Rhabdomyosarcoma, Hepatoblastoma, Endodermal Sinus Tumor, Rhabdoid Tumor

Clinical Trials

Identification of New Serum Diagnostic Markers of Hepatocellular Carcinoma

A Phase II Study of Single Tremelimumab With Regular Interval Durvalumab Plus Gemcitabine and Cisplatin in Locally Advanced Unresectable/Metastatic Combined Hepatocellular-cholangiocarcinoma

The Effects of a Nurse-led TGA-based Pre-rehabilitation Planning on Perioperative Outcomes in Patients With Liver Cancer: Study and Protocol

Single-cell Multiomics and Spatiotemporal Omics Analyze the Mechanism of Liver Degenerative Disease

Electrochemotherapy (ECT) in Patients With Primary Visceral Tumors and/or Secondary Visceral Localizations, of Any Histotype

ERFA

Interleukin-15 and -21 Armored Glypican-3-specific Chimeric Antigen Receptor Expressed in T Cells for Pediatric Solid Tumors

ELUCIDATE

Large Language Models Assist in Tumor MDT

STEREOLIVER

VOCAL

RADIANT

Optimizing Y90 Therapy for Radiation Lobectomy

STRAT-aHCC

(CLOCS-2)

Treat Primary and Metastatic Liver Tumors

QUS in HCC

PEDIR

Histotripsy Plus Chemotherapy vs Chemotherapy Alone for Advanced Colorectal Liver Metastasis

CKNO-HEP

pregabalin

EXOMIC

LUMIC

FASTRAK

ReLIVE

Yttrium Y-90 Radioembolization in Treating Patients With Metastatic Liver Cancer

TriNav Infusion System for the Evaluation of Fidelity Between 99mTc-MAA and Y90-Microspheres Hepatic Distribution for Dosimetry Treatment Planning

Clinical Study on the Safety, Efficacy, and Exploration of Immune Mechanisms of a Combined Multimodal Tumor Therapy System for Hepatic Malignancies

Interleukin-15 Armored Glypican 3-specific Chimeric Antigen Receptor Expressed in Autologous T Cells for Solid Tumors

MR Guidance for Liver and Pancreas

MOMENTUM

Development and Testing of a Patient-facing Educational Tool About Liver Cancer Prevention

Anti-CTLA4-NF mAb (BMS986218), Nivolumab, and Stereotactic Body Radiation Therapy for the Treatment of Metastatic Solid Malignancies

Safety and Efficacy of Transarterial ICG Fluorescence-Guided Laparoscopic Anatomical Liver Resection

I-GROWtoh

Riluzole For Preventing Cognitive Dysfunction in Ca Pts Receiving Chemo (REFOCUS): Pilot Trial

MICRO-VAR

Checkpoint Inhibition In Pediatric Hepatocellular Carcinoma

A DNAJB1-PRKACA Fusion Kinase Peptide Vaccine Combined With Glutamine Antagonist DRP-104, Nivolumab, and Ipilimumab in Patients With Advanced Stage Fibrolamellar Carcinoma (FLC)

GTI

ONE TEAM

Virtual Reality for GI Cancer Pain to Improve Patient Reported Outcomes

ESCAT

BC3402 w/ Tremelimumab + Durvalumab (STRIDE) in Hepatocellular Carcinoma

SBRT for Liver Tumors, Liver Metastases, and Pancreatic Tumors

SELECT-CAR-NK

EBNK-ST-001

Biobank for Cholestatic Liver Diseases.

Contrast Enhanced Ultrasound to Evaluate Response to Chemoembolization in Patients With Liver Tumors

IMPACT